Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. achieved a new 52-week high of USD 241.93, reflecting its strong performance in the miscellaneous industry. The company has seen a 12.08% increase over the past year, with a P/E ratio of 26.00 and a debt-to-equity ratio of 0.62, indicating solid financial health.

Charles River Laboratories International, Inc. has achieved a new 52-week high, reflecting its performance in the miscellaneous industry as a small-cap company. Over the past year, it has seen an 8.81% increase, with a P/E ratio of 26.00 and a debt-to-equity ratio of 0.62.

Charles River Laboratories International, Inc. has achieved a new 52-week high, reflecting its growth within the miscellaneous industry as a small-cap company. Over the past year, it has shown a performance increase, with a notable price-to-earnings ratio and a balanced financial structure, though it does not offer dividends.

Charles River Laboratories International, Inc. saw a notable rise in stock performance on May 28, 2026, reaching an intraday high. However, the company faces challenges, including a decline in net profit and ROCE, alongside rising raw material costs, which may affect future profitability.

Charles River Laboratories International, Inc. saw a notable increase in stock performance on May 5, 2026, reaching an intraday high. The company has demonstrated resilience over the past week and month, although it has faced challenges, including a decline in net profit and a lower return on capital employed.

Charles River Laboratories International, Inc. faced a notable decline in stock value, contrasting with the S&P 500's modest decrease. The company has struggled over the past year and three years, with significant drops in net profit and a lower return on capital employed, while maintaining a market capitalization of USD 7,503 million.

Charles River Laboratories International, Inc. has experienced notable stock fluctuations, with a recent closing price of 176.94. The company has outperformed the S&P 500 over the past year, but year-to-date performance shows a decline. Technical indicators present mixed signals, reflecting the company's current market positioning.

Charles River Laboratories International, Inc. has experienced notable stock price fluctuations, currently priced at $175.55. The company has shown mixed technical indicators and varied performance compared to the S&P 500, with a year-to-date return of -12.00% but a one-year return of 26.23%, reflecting its resilience.

Charles River Laboratories International, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, currently priced at $153.05, has shown notable volatility over the past year, with a 52-week range between $91.86 and $228.88, and has underperformed compared to major market indices.

Charles River Laboratories International, Inc. faced notable stock volatility on March 12, 2026, with a significant decline and an intraday low. Over the past week and month, the stock has shown considerable decreases, reflecting broader underperformance compared to the S&P 500 and challenges in financial metrics and profit margins.

Charles River Laboratories International, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock has shown notable price variations, with a mixed technical outlook. While it outperformed the S&P 500 over the past week, its longer-term performance has been less favorable compared to the broader market.

Charles River Laboratories International, Inc. reported flat financial performance for the quarter ending December 2025, despite strong operating cash flow and improved raw material costs. Key metrics like inventory and debtors turnover ratios were impressive, but challenges persist with low return on capital employed and negative earnings per share.

Charles River Laboratories International, Inc. has recently seen a revision in its evaluation, with current stock price at $174.95. The company has experienced significant volatility over the past year, with a notable weekly return of 19.02%, although year-to-date performance shows a decline compared to the S&P 500.

Charles River Laboratories International, Inc. has experienced notable stock volatility over the past year, with a current price of $148.56. Technical indicators show mixed signals, and the company has underperformed compared to the S&P 500, highlighting challenges in aligning with broader market trends.